Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Limiting Fees from Industry to Academic Consultants
Massachusetts General Hospital and Brigham and Women's Hospital have placed limits on the outside, institutional pay a number of their senior officials can receive from biotechnology and pharmaceutical companies on whose boards these officials may sit. The decisions were largely dictated by complaints from within and outside the bioindustry and academia over conflict-of-interest issues. Do you think such pay limits represent a good policy move?